Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer
Clinical trial NCT00332852 · COMPLETED
Trial details
- NCT number
- NCT00332852
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2010-07-01
- Enrollment
- 655
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.